As shown in Figure 7, STING agonist (ADU) was used to improve tumor immunogenicity and adeno-associated virus-based-PD1 (AAV-PD1) was utilized to secret therapeutic PD-1 proteins to block the interaction between PD-1 and PD-L1 for restoring immunotherapy. Here, CD274 is linked to neoplasm.